JKI 22 Pill - beige elliptical/oval
Generic Name: tofacitinib
Pill with imprint JKI 22 is Beige, Elliptical/Oval and has been identified as Xeljanz XR 22 mg. It is supplied by Pfizer Inc.
Xeljanz XR is used in the treatment of ulcerative colitis; rheumatoid arthritis; psoriatic arthritis; ankylosing spondylitis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 22 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JKI 22
Xeljanz XR
- Generic Name
- tofacitinib
- Imprint
- JKI 22
- Strength
- 22 mg
- Color
- Beige
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0502
More about Xeljanz XR (tofacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
